MajesTEC-9
Phase 3 Clinical Trial Comparing a Study Medication Alone Versus Pomalidomide, Bortezomib, Dexamethasone or Carfilzomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
What's the purpose of the trial?
The goal of this clinical trial is compare the safety and efficacy of a study medication by itself versus two other combinations, Pomalidomide, Bortezomib and Dexamethasone or Carfilzomib and Dexamethasone in participants who have relapsed or refractory multiple myeloma.
Accepting patients
Participating Centers
There are 21 centers participating in this trial. Enter a location below to find the closest center.
Arms / Cohorts
Explore eligibility, treatments and learn more about potential cohorts.
Accepting patients
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.